Skip to content

Clinical trials

Phase 3 Dermatitis, Atopic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 3 Country / region: Germany Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20043
20061
20131
20142
20151
20161
20174
201817
20196
20205
20211
20224
20238
20246
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Active, not recruiting7
Terminated2
Enrolling by invitation1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company10
AbbVie7
LEO Pharma7
Pfizer7
Regeneron Pharmaceuticals6
Amgen5
Incyte Corporation4
Sanofi4
Almirall, S.A.3
Astellas Pharma Inc3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic63
Eczema27
Dermatitis7
Skin Diseases6
Pruritus4
Genetic Diseases, Inborn2
Hypersensitivity2
Hypersensitivity, Immediate2
Immune System Diseases2
Skin Diseases, Eczematous2

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.